When PE firms push each other to the limit, the buyer often lives to regret it. Insignia Financial is a fascinating test.

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

BizCare Benefits, a company that says it has backing from Bain Capital, is ramping up ICHRA operations by providing ICHRA ...

Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.

The number of individuals with more than $30 million of assets is expected to grow by 50% between 2023 and 2028, according to ...

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Let Travel + Leisure take you on a retail journey through Europe’s most shoppable cities — Paris, Milan, Madrid, Stockholm, ...

Insignia has granted suitor Bain Capital limited due diligence after the PE firm matched ... costly complexity of integrating two bank wealth businesses is causing a big disconnect between reported ...

The Miami-based hedge fund is poised to slash the size of its local workspace and move it to River North. But another firm is ...

After its initial advances were rejected in December, Bain ... a big disconnect between reported and underlying earnings,” the analysts, led by Richard E. Wiles, told clients after CC Capital ...